Psyence Group

Psyence Group

Biotechnology Research

Toronto, Ontario 2,002 followers

Psyence Group sets the global standard for natural psychedelics

About us

Psyence (PSYG) is a clinical-stage life science biotechnology company pioneering the use of natural psilocybin in mental health and well‑being. We have a focus on these conditions in the context of palliative care. Psyence is listed on the Canadian Stock Exchange (CSE: PSYG) and on the US OTCQB® Venture Market (OTCQB: PSYGF). Our diversified business has a global footprint with operations in multiple legal jurisdictions. We operate one of the first federally licensed commercial psilocybin cultivation and production facilities in the world in Southern Africa. For more information: www.psyence.com

Website
https://www.psyence.com/
Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
Toronto, Ontario
Type
Public Company
Founded
2019
Specialties
mental health, psychedelics, psilocybin, and nutraceuticals

Locations

Employees at Psyence Group

Updates

Similar pages

Browse jobs

Funding

Psyence Group 4 total rounds

Last Round

Post IPO equity

US$ 1.4M

See more info on crunchbase